000 02308cam  2200409zi 4500
0019.908429
003CaOODSP
00520221107181645
006m     o  d f      
007cr cn|||||||||
008220223t20212022qucabd  o    f000 0 eng d
020 |a9780660422022
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH139-37/2022E-PDF
1001 |aGilbert, Marie-Line, |eauthor.
24510|aAt-a-glance : |bthe emergence of nitazenes and brorphine in Canada since 2019 : a working group report / |cMarie-Line Gilbert, Michèle Boileau-Falardeau, Cindy Leung Soo, Luc Chicoine, Michael Bushey, Vincent Marleau, Cathy Copeland, Christian Gagne, Thomas Berrigan.
24610|aEmergence of nitazenes and brorphine in Canada since 2019 : |ba working group report
264 1|aLongueuil, QC : |bHealth Canada Drug Analysis Service : |bRoyal Canadian Mounted Police : |bCanada Border Services Agency, |c2021.
264 4|c©2022
300 |a1 online resource (9 pages) : |billustrations, maps, graphs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |aIssued also in HTML format.
500 |aIssued also in French under title: Survol : la présence de nitazènes et de brorphine au Canada depuis 2019 : rapport du groupe de travail.
520 |a"This report aims at presenting the result of a pilot project based on a collaborative work between the DAS, the Canada Border Services Agency (CBSA) and the Royal Canadian Mounted Police (RCMP) related to nitazenes and Brorphine in order to draw a more complete picture of the situation in Canada"--Goal & Focus, page 2.
650 0|aOpioids.
650 0|aBenzimidazoles|zCanada.
7101 |aCanada. |bHealth Canada. |bDrug Analysis Service, |eissuing body.
7102 |aRoyal Canadian Mounted Police, |eissuing body.
7102 |aCanada Border Services Agency, |eissuing body.
77508|tSurvol : |w(CaOODSP)9.908430
85640|qPDF|s1.25 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H139-37-2022-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/publications/healthy-living/emergence-nitazenes-brorphine-canada-2019.html